首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1663459

集中式患者监测系统市场，按患者数量、按最终用户、按国家和地区划分 - 2025 年至 2032 年全球行业分析、市场规模、市场份额及预测

Centralized Patient Monitoring System Market, By Number of Patients, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: 2025年01月04日 | 出版商:

AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

简介目录

报告重点

2024 年集中式病人监测系统市场规模价值为 6.145 亿美元，2025 年至 2032 年期间的复合年增长率为 7.10%。

集中式病人监护系统市场-市场动态

改善医疗基础设施

在全球范围内，改善医疗保健基础设施对于促进集中式病人监测系统的使用和有效性至关重要。医疗机构在基础设施现代化升级的过程中，经常会投资于能够实现集中监控功能的尖端技术。为了促进部门和医疗保健提供者之间的资料流，这需要建立可互通的系统，整合电子健康记录 (EHR)，并建立强大的 IT 框架。这些改进使得在多个地点即时监控患者变得更加容易，从而保证及时治疗并改善治疗效果。此外，医疗保健基础设施的改善也支持集中监控患者所需的先进医疗设备和感测器的部署。现代医院和医疗机构越来越多地配备先进的监测设备，可以轻鬆记录生理资料和生命征象。这些发展提高了患者数据的准确性和可靠性，同时也使医务人员能够迅速果断地采取行动，从而全面提高患者护理的标准。

集中式病人监护系统市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 7.10%

根据患者人数细分，预计患者人数<16 的类别将在 2024 年占据最大市场份额

根据最终用途细分，医院将成为 2024 年的主要细分市场

从地区来看，北美是 2024 年最大的收入来源

集中式病人监测系统市场-細項分析：

全球集中式病人监测系统市场根据患者数量、最终用户和地区进行细分。

根据患者数量，市场分为<16 名患者、17-32 名患者、33-64 名患者和>64 名患者。到 2024 年，市场将以患者人数少于 16 人的类别为主。医院专科护理单位、门诊部和小型诊所是监测少于 16 名患者的系统的主要使用者。这些配置通常使用小型集中监控站或软体平台，与少量穿戴式装置或床边监视器互动。对于特定数量的患者，它们提供关键的监测功能，保证持续的生命征象监测，并在发生危机或其他重大事件时及时向医疗专业人员发出警报。

根据最终用户，市场分为医院、创伤中心、门诊手术中心和其他。在这个市场中，医院占据着最大的份额。他们使用集中式病人监控系统来监控不同部门和单位的各种病人状况。这些系统对于急诊室、普通病房、重症监护室 (ICU) 和手术室至关重要，因为这些地方需要持续的生命征象和病患状态监测，以便及时介入和有效的临床管理。电子健康记录 (EHR)、遥测系统和床边监视器都与医院的集中监测站整合。这使得医疗专业人员能够追踪患者趋势，优化工作流程，并改善护理协调，以获得更好的患者治疗结果。

集中式病人监护系统市场-地理洞察

2024 年，北美在全球集中式病人监护系统市场占据主导地位，其特点是强大的医疗保健系统、广泛使用尖端医疗技术以及严格的监管环境。高昂的医疗成本、技术进步以及对病人安全和护理品质的关注是推动北美（尤其是美国和加拿大）集中式患者监测系统市场发展的主要因素。为了改善临床决策、简化工作流程和改善病患治疗效果，这些地区率先在医院、ASC 和创伤中心采用集中监控解决方案。这些解决方案整合了先进的遥测系统、床边监视器和集中监控站。

然而，在整个预测期内，预计亚太地区将出现最快的复合年增长率，这得益于基础设施支出的增长、医疗保健投资的增加以及数位健康技术的日益广泛的使用。为了增加医疗机会和提高医疗质量，中国、印度和日本等国家正在投资远距医疗、远距病人监控和智慧医疗计画。亚太地区的集中监控系统支援即时病人监控、资料分析和远距医疗服务，满足从远距诊所到城市医院的一系列医疗保健需求。该地区对技术整合和医疗保健创新的重视，为寻求扩大影响力和应对不断变化的医疗保健问题的市场参与者提供了巨大的成长前景。

集中式病人监测系统市场-竞争格局：

在竞争激烈的集中病人监护系统产业中，存在着许多重要的竞争对手。为了提高市场地位，产业内的公司专注于研发、产品发布、策略联盟和併购。集中式病人监护系统市场的领导公司包括飞利浦医疗集团 (Philips Healthcare)、荷兰皇家飞利浦公司 (Koninklijke Philips NV)、Infinium Medical、环球医疗仪器 (Universal Medical Instruments) 和通用电气医疗集团 (GE Healthcare) 等。为了满足消费者和医疗保健日益增长的需求，这些行业参与者也一直在寻求投资和创新。例如，2023年5月，美国食品药物管理局（FDA）批准了雅培的Assert-IQTM可植入心臟监视器（ICM），为心律不整患者提供了长期监测和诊断评估的新选择。透过此项批准，雅培能够协助医生远端管理和治疗患者的连网医疗设备产品线得到了扩展。

近期发展

2024 年 11 月：FDA 批准 GE HealthCare 将 Novii+ 产妇和胎儿监测系统扩大用于怀孕 34 週或以上的孕妇。 Novii+ 透过非侵入性测量和显示子宫活动、孕妇心率和胎儿心率，为患者在医院期间提供舒适性和机动性。

2023 年 1 月：Senet 和 Telli Health 推出了首款支援 LoRaWAN 的远端病人监控 (RPM) 设备。透过使医疗从业者能够联繫到更多位于服务不足和偏远地区（如原住民社区）的患者，这项技术将提高医疗保健的公平性和包容性，并为未来的智慧家庭服务奠定基础。

介绍
- 按地区分類的细分市场占有率分析
北美洲
- 概述
- 北美集中式病人监护系统主要製造商
- 北美市场规模及预测（按国家/地区）
- 北美市场规模及预测（按患者数）
- 北美市场规模及预测（依最终用户划分）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲集中式病人监护系统主要製造商
- 欧洲市场规模及预测（按国家）
- 欧洲市场规模及预测（按患者数）
- 欧洲市场规模及预测（按最终用户）
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区集中式病患监护系统主要製造商
- 亚太地区市场规模及预测（依国家）
- 亚太市场规模及预测（依患者数）
- 亚太市场规模及预测（依最终用户）
- 印度
- 中国
- 韩国
- 日本
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲集中式病患监测系统主要製造商
- 拉丁美洲市场规模及预测（按国家/地区）
- 拉丁美洲市场规模及预测（按患者数）
- 拉丁美洲市场规模及预测（按最终用户划分）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲集中式病人监护系统主要製造商
- 中东和非洲市场规模及预测（按国家/地区）
- 中东和非洲市场规模及预测（按患者数）
- 中东和非洲市场规模及预测（按最终用户划分）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 其他地区

第 10 章：主要供应商分析-集中式病患监测系统产业

竞争仪錶板
公司简介
- Philips Healthcare
- Koninklijke Philips NV
- Infinium Medical
- Universal Medical Instruments
- GE Healthcare
- Abbott Laboratories
- Nihon Kohden Corporation
- Nihon Kohden
- Sunray
- Mediana
- MindRay
- Criticare Systems Inc.
- Honeywell International Inc.
- Others

第 11 章：360 度分析师视角

第 12 章：附录

研究方法
参考
缩写
免责声明
联络我们

简介目录

Product Code: ANV4634

REPORT HIGHLIGHT

Centralized Patient Monitoring System Market size was valued at US$ 614.5 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.

Centralized patient monitoring systems are made up of a network of interconnected medical equipment and software that make it possible to continuously monitor and gather vital signs and other pertinent information from patients. Healthcare professionals can access real-time patient data using these technologies, identify important changes, and make prompt therapeutic decisions. Healthcare providers can increase productivity, monitor more patients at once, and improve patient outcomes by centralizing patient data. The growing demand for remote patient monitoring, improvements in medical technology, and an increased emphasis on enhancing patient outcomes are all driving the market for centralized patient monitoring systems. Among the many advantages of centralized patient monitoring systems are ongoing patient observation, early anomaly identification, and prompt intervention. However, obstacles like interoperability problems, data security concerns, and the demand for qualified healthcare workers could impede the centralized patient monitoring systems industry expansion. Nevertheless, the market offers chances for manufacturers, healthcare providers, and tech developers to create cutting-edge centralized patient monitoring systems and revolutionize the way healthcare is delivered.

Centralized Patient Monitoring System Market- Market Dynamics

Improved Healthcare Infrastructure

Globally, improved healthcare infrastructure is essential to promoting the use and effectiveness of centralized patient monitoring systems. Healthcare facilities frequently make investments in cutting-edge technologies that enable centralized monitoring capabilities as they modernize their infrastructure. In order to facilitate data flow between departments and healthcare providers, this entails putting in place interoperable systems, integrating electronic health records (EHRs), and building strong IT frameworks. These improvements make it easier to monitor patients in real-time across several locations, guaranteeing prompt treatments and improved therapeutic results. Additionally, the deployment of advanced medical equipment and sensors required for centralized patient monitoring is supported by improved healthcare infrastructure. Modern hospitals and healthcare facilities are increasingly outfitted with cutting-edge monitoring devices that can easily record physiological data and vital signs. These developments improve patient data's accuracy and dependability while also empowering medical personnel to act quickly and decisively, which raises the standard of patient care overall.

Centralized Patient Monitoring System Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.10% over the forecast period (2025-2032)

Based on the number of patients segmentation, the <16 number of patients category was predicted to show the maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Centralized Patient Monitoring System Market- Segmentation Analysis:

The Global Centralized Patient Monitoring System Market is segmented on the basis of Number of Patients, End-user, and Region.

On the basis of number of patients, the market is segregated into <16 number of patients, 17-32 number of patients, 33-64 number of patients, and >64 number of patients. In 2024, the market was dominated by the <16 number of patients category. Hospital-specialized care units, outpatient departments, and tiny clinics are the main users of systems made for monitoring fewer than 16 patients. These configurations usually make use of small, centralized monitoring stations or software platforms that interface with a small number of wearables or bedside monitors. For a specific number of patients, they offer crucial monitoring capabilities that guarantee ongoing vital sign surveillance and timely alerting of medical professionals in the event of crises or other significant occurrences.

Based on end-user, the market is divided into Hospitals, Trauma Centers, Ambulatory Surgical centers, and Others. In this market, hospitals make up the largest segment. They use centralized patient monitoring systems to monitor a variety of patient statuses in different departments and units. These systems are essential in emergency rooms, general wards, intensive care units (ICUs), and operating theatres where ongoing vital signs and patient status monitoring are necessary for prompt intervention and efficient clinical management. Electronic health records (EHRs), telemetry systems, and bedside monitors are all integrated with centralized monitoring stations in hospitals. This allows medical professionals to track patient trends, optimize workflow, and improve care coordination for better patient outcomes.

Centralized Patient Monitoring System Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Centralized Patient Monitoring Systems, distinguished by strong healthcare systems, widespread use of cutting-edge medical technology, and strict regulatory environments. High healthcare costs, technology advancements, and a focus on patient safety and care quality are the main factors driving the market for centralized patient monitoring systems in North America, especially in the US and Canada. In order to improve clinical decision-making, streamline workflow, and enhance patient outcomes, these regions are at the forefront of the adoption of centralized monitoring solutions across hospitals, ASCs, and trauma centres. These solutions integrate advanced telemetry systems, bedside monitors, and centralized monitoring stations.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR driven by growing infrastructure spending, increased investments in healthcare, and the growing use of digital health technologies. To increase access to and the quality of healthcare, nations like China, India, and Japan are investing in telemedicine, remote patient monitoring, and smart healthcare projects. Real-time patient monitoring, data analytics, and telemedicine services are supported by centralized monitoring systems in Asia Pacific, which serve a range of healthcare requirements from distant clinics to urban hospitals. The region's emphasis on technology integration and healthcare innovation offers significant growth prospects for market participants looking to broaden their reach and tackle changing healthcare issues.

Centralized Patient Monitoring System Market- Competitive Landscape:

There are a number of important competitors in the fiercely competitive centralized patient monitoring system industry. To improve their market position, companies in the industry concentrate on R&D, product launches, strategic alliances, and mergers and acquisitions. Among the leading companies in the market for centralized patient monitoring systems are Philips Healthcare, Koninklijke Philips N.V., Infinium Medical, Universal Medical Instruments, and GE Healthcare, among others. In order to meet the growing demands of consumers and healthcare, these industry participants are also always looking for investments and innovations. For instance, in May 2023, the U.S. Food and Drug Administration (FDA) approved Abbott's Assert-IQTM insertable cardiac monitor (ICM), providing patients with irregular heartbeats with a new alternative for long-term monitoring and diagnostic evaluation. With this approval, Abbott's line of linked medical devices that can assist physicians in remotely managing and treating patients is expanded.

Recent Development

November 2024: The FDA has approved GE HealthCare's expanded use of the Novii+ maternal and fetal monitoring system for expectant mothers who are 34 weeks or more along. Novii+ gives patients comfort and mobility in the hospital by noninvasively measuring and displaying uterine activity, maternal heart rate, and fetal heart rate.

January 2023: Senet and Telli Health introduced the first LoRaWAN-enabled remote patient monitoring (RPM) devices. By enabling healthcare practitioners to contact more patients in underserved and remote places, such as indigenous communities, this technology will improve healthcare fairness and inclusivity and lay the groundwork for future smart home services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Philips Healthcare
Koninklijke Philips N.V.
Infinium Medical
Universal Medical Instruments
GE Healthcare
Abbott Laboratories
Nihon Kohden Corporation
Nihon Kohden
Sunray
Mediana
MindRay
Criticare Systems Inc.
Honeywell International Inc.
Others

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY NUMBER OF PATIENTS- MARKET ANALYSIS, 2019 - 2032

<16 number of patients
17-32 number of patients
33-64 number of patients
>64 number of patients

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Trauma Centers
Ambulatory Surgical centers
Others

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Centralized Patient Monitoring System Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Centralized Patient Monitoring System Market Snippet by Number of Patients
- 2.1.2. Centralized Patient Monitoring System Market Snippet by End-user
- 2.1.3. Centralized Patient Monitoring System Market Snippet by Country
- 2.1.4. Centralized Patient Monitoring System Market Snippet by Region
2.2. Competitive Insights

3. Centralized Patient Monitoring System Key Market Trends

3.1. Centralized Patient Monitoring System Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Centralized Patient Monitoring System Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Centralized Patient Monitoring System Market Opportunities
3.4. Centralized Patient Monitoring System Market Future Trends

4. Centralized Patient Monitoring System Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Centralized Patient Monitoring System Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Centralized Patient Monitoring System Market Landscape

6.1. Centralized Patient Monitoring System Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Centralized Patient Monitoring System Market - By Number of Patients

7.1. Overview
- 7.1.1. Segment Share Analysis, By Number of Patients, 2024 & 2032 (%)
- 7.1.2. <16 number of patients
- 7.1.3. 17-32 number of patients
- 7.1.4. 33-64 number of patients
- 7.1.5. >64 number of patients

8. Centralized Patient Monitoring System Market - By End-user

8.1. Overview
- 8.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
- 8.1.2. Hospitals
- 8.1.3. Trauma Centers
- 8.1.4. Ambulatory Surgical centers
- 8.1.5. Others

9. Centralized Patient Monitoring System Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Centralized Patient Monitoring System Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Centralized Patient Monitoring System Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.7. France
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. France Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.7.4. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.8. Italy
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. Italy Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.8.4. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.9. Spain
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.10. United Kingdom
  - 9.3.10.1. Overview
  - 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.3. United Kingdom Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.10.4. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.11. Russia
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Russia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.12. Netherlands
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Netherlands Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.13. Sweden
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Sweden Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
  - 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.2. Poland Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.14.3. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
  - 9.3.15.1. Overview
  - 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.15.3. Rest of the Europe Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Centralized Patient Monitoring System Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.4.8. South Korea
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. South Korea Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.4.8.4. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.4.9. Japan
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. Japan Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.4.9.4. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Centralized Patient Monitoring System Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Centralized Patient Monitoring System Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Centralized Patient Monitoring System Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Philips Healthcare
- 10.2.2. Koninklijke Philips N.V.
- 10.2.3. Infinium Medical
- 10.2.4. Universal Medical Instruments
- 10.2.5. GE Healthcare
- 10.2.6. Abbott Laboratories
- 10.2.7. Nihon Kohden Corporation
- 10.2.8. Nihon Kohden
- 10.2.9. Sunray
- 10.2.10. Mediana
- 10.2.11. MindRay
- 10.2.12. Criticare Systems Inc.
- 10.2.13. Honeywell International Inc.
- 10.2.14. Others